Skip to main content
. 2009 Oct 7;2009(4):CD007441. doi: 10.1002/14651858.CD007441.pub2

2. Summary of outcomes: adverse events and withdrawals.

    Adverse events Withdrawals
Study ID Treatment Any Serious Adverse event Other
Moller 2008 (1) Lornoxicam 8 mg SR, n = 80
(2) Lornoxicam 8 mg QR, n = 80
(3) Placebo, n = 40		 at 7 days:
(1) 39/80
(2) 43/80
(3) 14/40		 None None None
Norholt 1995 (1) Lornoxicam 4 mg, n = 43
(2) Lornoxicam 8 mg, n = 45
(3) Lornoxicam 16 mg, n = 48
(4) Lornoxicam 32 mg, n = 48
(5) Ketorolac 10 mg, n = 46
(6) Placebo, n = 48		 No usable data None reported None None
Patel 1991 (1) Lornoxicam 2 mg, n = 30
(2) Lornoxicam 4 mg, n = 30
(3) Lornoxicam 8 mg, n = 30
(4) Aspirin 650 mg, n = 30
(6) Placebo, n = 30		 at 8 h:
(1) 3/30
(2) 1/30
(3) 2/30
(4) 2/30
(5) 2/30		 None None None

QR ‐ quick release; SR ‐ slow release